American Soybean Association discusses its disappointment with the MAHA report

Ag groups across the board have been vocal since the “Make America Healthy Again” report was released. The Farm Bureau called it “disappointing,” and soy groups are also pushing back.

The American Soybean Association calls the report “unscientific,” and says its mission will actually make Americans less healthy.

The Association’s Alan Meadows joined RFD-TV’s Tammi Arender to discuss his initial reaction to the report, if he will be a part of the talks regarding pesticides, and his thoughts on the seed oils portion of the report.

Click here to read the full MAHA Report

Related Stories
Mexico has fallen behind by several hundred thousand acre-feet in required water deliveries to the United States, a shortfall that has had devastating consequences across the Rio Grande Valley.
U.S. Senator Roger Marshall of Kansas discusses expected changes to the 45Z tax credit and what they could mean for agriculture and rural America.
Shrinking slaughter capacity may delay heifer retention, complicating herd rebuilding plans.
Securing Critical Water Resources for South Texas Agriculture
RealAg Radio host Shaun Haney says farmers there are already sounding the alarm about what this could mean for the future of ag research.

LATEST STORIES BY THIS AUTHOR:

Lewis Williamson with HTS Commodities joined us to provide analysis on the January WASDE report and expectations for grain markets going forward.
Market reaction was bearish for corn and soybeans, with analysts noting that abundant supplies amid tepid demand could keep price pressure on agricultural commodities.
The Farm Bureau’s honor highlights the important role farm dogs play on operations across the country, serving as dependable workers and trusted companions.
Logistics capacity remains available, but winter volatility favors flexible delivery and marketing plans. NGFA President Mike Seyfert provides insight into grain transportation trends, trade policy, and priorities for the year ahead.
Rising adoption of GLP-1 drugs may gradually reshape food demand, with potential downstream effects on protein markets and consumer purchasing patterns.
Traders are keeping a close eye on China’s soybean purchases as markets track export sales, shipments, and progress toward the ‘magical’ 12 million ton target promised last year.